Myriad Genetics, Inc. - MYGN - stock price prediction, stock price target, analyst ratings from 16 analysts
Myriad Genetics, Inc. has a share price target of US$ 9, revenue growth forecast of -3.1%, and profit growth estimate of 53.4% for FY25, based on top 16 analyst calls.